# Open Label, Phase I ZD6474 Head and Neck Cancer Study

> **NCT00450138** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 48 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** ZD6474 (vandetanib)
- **DRUG:** Cisplatin
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT00450138
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2009-11
- **Final completion:** 2011-11
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2016-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00450138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00450138, "Open Label, Phase I ZD6474 Head and Neck Cancer Study". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00450138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*